Diagnosis and treatment of polonium poisoning Polonium poisoning

Clinical Toxicology

Volumn 47, Issue 5, 2009, Pages 379-392

  Jefferson, Robert D ^a   Goans, Ronald E ^b   Blain, Peter G ^a   Thomas, Simon H L ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b TULANE UNIVERSITY   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Acute radiation sickness; Chelation therapy; Polonium

Indexed keywords

2,3 DIMERCAPTOPROPYL PHTHALAMIDIC ACID; CHELATING AGENT; DIMERCAPROL; N,N' DI(2 HYDROXYETHYL)ETHYLENE DIAMINE N,N' BISCARBODITHIOATE; OXATHIOL; PENICILLAMINE; POLONIUM; SUCCIMER; UNCLASSIFIED DRUG; UNITHIOL; ANTIDOTE;

ACUTE RADIATION SYNDROME; ANOREXIA; BLOOD CELL COUNT; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; BRAIN EDEMA; CHELATION THERAPY; DIARRHEA; DRUG MECHANISM; DRUG MEGADOSE; DRUG SCREENING; FECES ANALYSIS; GASTRIC SUCTION; GASTROINTESTINAL DISEASE; HAIR LOSS; HALF LIFE TIME; HUMAN; INTOXICATION; LYMPHOCYTOPENIA; MENINGITIS; MORTALITY; NAUSEA; NONHUMAN; POLONIUM POISONING; REVIEW; SINGLE DRUG DOSE; STOMACH LAVAGE; TOXICOKINETICS; URINALYSIS; VASCULITIS; VOMITING; ANIMAL; DISEASE MODEL; PATHOPHYSIOLOGY; RADIATION DOSE; TISSUE DISTRIBUTION;

ANIMALIA;

ACUTE RADIATION SYNDROME; ANIMALS; ANTIDOTES; CHELATING AGENTS; DISEASE MODELS, ANIMAL; HUMANS; POLONIUM; RADIATION DOSAGE; TISSUE DISTRIBUTION;

EID: 67449123005     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650902956431     Document Type: Review

References (79)

1. Obituary: Alexander Litvinenko 2006. http://news.bbc.co.uk/1/hi/uk/ 6163502.stm. Accessed 4 March 2009.
2. Roessler G. Why 210Po? Health Phys News 2007; 35:1-9.
3. Singh NK. Polonium-210 in news: An allegory of a misappropriated science. Br J Clin Pharmacol 2007; 64:714.
4. Le MH. Polonium 210, exposed. J Med Toxicol 2007; 3:82-84.
5. Chemie.De Information Service. Polonium. http://www.chemie.de/ lexikon/e/Polonium/. Accessed 4 March 2009.
6. WebElements. Polonium: The Essentials. http://www.webelements. com/polonium/. Accessed 4 March 2009.
7. Hoff RW, Hollander JM. Energy levels of polonium-210. Phys Rev 1958; 109:447-456.
8. Moore HE. Sources of polonium-210 in atmosphere. Environ Sci Technol 1976; 10:586-591.
9. Argonne National Laboratory Environmental Science Division. Polonium, Human Health Fact Sheet. 2005. http://www.ead.anl.gov/pub/doc/polonium.pdf. Accessed 3 April 2009.
10. Argonne National Laboratory Environmental Science Division. Natural Decay Series: Uranium, Radium, and Thorium. 2005. http:// www.ead.anl.gov/pub/doc/ natural-decay-series.pdf. Accessed 3 April 2009.
11. Meyer R, Zylka-Menhorn V. What makes polonium 210 so dangerous. Deutsches Arzeblatt 2006; 49:103.
12. Royal Society of Chemistry. Polonium-210: A Deadly Element. 2007. http://www.rsc.org/chemistryworld/Issues/2007/January/Polonium210. asp. Accessed 4 March 2009.
13. Harrison J, Leggett R, Lloyd D, Phipps A, Scott B. Polonium-210 as a poison. J Radiol Prot 2007; 27:17-40.
14. Moecke H, Bey T, Koenig KL, Rechenbach P, Schallhorn J. Polonium- 210 - Eine Kurzinformation (Polonium-210 - an overview). Notfall Rettungsmed 2007; 10:37-40.
15. Scott BR. Health risk evaluations for ingestion exposure of humans to polonium-210. Dose Response 2007; 5:94-122.
16. National Council on Radiation Protection and Measurement (NCRP). Management of Persons Accidentally Contaminated with Radionuclides. Bethesda, MD: National Council for Radiation Protection and Measurement; 1980.
17. National Council on Radiation Protection and Measurements. Polonium Contamination. 2006. http://www.ncrponline.org/Learn-More/Did-You- Know-65. Accessed 4 March 2008.
18. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Uranium. http://www.atsdr.cdc.gov/toxprofiles/ tp150.html. Accessed 4 March 2009.
19. Morris KJ, Townsend KMS, Batchelor AL. Studies of alveolar cell morphometry and mass clearance in the rat lung following inhalation of an enriched uranium dioxide aerosol. Radiat Environ Biophys 1989; 28:141-154.
20. Stannard JN. Radioactivity and Health a History. Pacific Northwest Laboratory, US Department of Energy. Springfield, VA: Office of Scientific and Technical Information; 1988.
21. Ladinskaya LA, Parfenov YD, Popov DK, Fedorova AV. 210Pb and 210Po content in air, water, foodstuffs, and the human body. Arch Environ Health 1973; 27:254-258.
22. Fink R. Biological studies with polonium, radium, and plutonium. New York-Toronto-London: McGraw-Hill; 1950.
23. Kalmykov L, Krupchitshaya K, Stratsenko V, Rutkevich N. The dynamics of Po210 excretion from the human body. Med Radiol 1969; 12:26-30.
24. Gusakova A, Drutman R, Malysheva M, Soldatova V. Dose assessment and the possibility of clinical recognition of disease associated with the ingestion of Po210 into the human body. Med Radiol 1964; 8:51-60.
25. Leggett RW, Eckerman KF. A systemic biokinetic model for polonium. Sci Total Environ 2001; 275:109-125.
26. Gasteva G. Acute radiation sickness caused by uptake of polonium. In: Gusakova A, Selidovkin G, eds. Human Radiation Injuries. Moscow: IzdAT; 2001:99-103.
27. Stannard N, Casarett G. Concluding comments on biological effects of alpha-particle emitters in soft tissue as exemplified by experiments with polonium 210. Radiat Res Suppl 1964; 5:398-434.
28. Seider A. Metabolism and toxicology of polonium and its removal from the body. Gmelin Handbook. Polonium supplement. vol.1. http:// www.toxcenter.de/ buecher/tox-info/terrorgifte/polonium/dmps-metall- 00230.pdf. Accessed 17 March 2009.
29. International Commission on Radiological Protection. ICRP Publication 100: Human Alimentary Tract Model for Radiological Protection. Oxford, UK: Elsevier; 2007.
30. International Commission on Radiological Protection. ICRP Publication 68: Dose Coefficients for Intakes of Radionuclides by Workers. Oxford, UK: Elsevier; 1995.
31. Berger ME, Leonard RB, Ricks RC, Wiley AL, Lowry PC, Flynn DF. Hospital Triage in the First 24 Hours after a Nuclear or Radiological Disaster. http://orise.orau.gov/reacts/files/triage.pdf. Accessed 4 March 2009.
32. Berger ME, Christensen DM, Lowry PC, Jones OW, Wiley AA. Medical management of radiation injuries: Current approaches. Occup Med Oxford 2006; 56:162-172.
33. Center for Disease Control (CDC). Radiation Emergencies. http:// www.bt.cdc.gov/radiation/index.asp. Accessed 4 March 2009.
34. Goans RE, Holloway EC, Berger ME, Ricks RC. Early dose assessment following severe radiation accidents. Health Phys 1997; 72:513-518.
35. International Atomic Agency (IAEA). Publications on Accident Response. http://www-pub.iaea.org/MTCD/publications/accres.asp?p=1. Accessed 4 March 2009.
36. Jarrett DG, Sedlak RG, Dickerson WE, Reeves GI. Medical treatment of radiation injuries-Current US status. Radiat Meas 2007; 42:1063-1074.
37. Radiation Event Medical Management. 2008. http://www.remm.nlm.gov/. Accessed 4 March 2009.
38. Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO, Dainiak N, Strategic National Stockpile Radiation Working Group. Medical management of the acute radiation syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 2004; 140:1037-1051.
39. Goans R. Clinical care of the radiation accident victim: patient presentation, assessment and initial diagnosis. In: Ricks R, Berger M, O'Hara F, eds. The Medical Basis for Radiation-Accident Preparedness. New York: Parthenon; 2002:11-22.
40. Health Protection Agency. High Dose Radiation Effects and Tissue Injury. Report of the independent advisory group on ionising radiation. March 2009 http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 1237362785677. Accessed 20 March 2009.
41. Trestrail J. Criminal Poisoning: An Investigational Guide for Law Enforcement, Toxicologists, Forensic Scientists and Attorneys. Totowa, NJ: Humana Press; 2000.
42. International Atomic Energy Agency (IAEA). Cytogenetic Analysis for Radiation Dose Estimate. Vienna, Austria: IAEA; 2001.
43. Health Protection Agency. Method for the Assessment of Polonium- 210 in Urine Being used by HPA for the UK Po-210 Incident. 2006. http://www.hpa.org.uk/ web/HPAwebFile/HPAweb-C/1194947324589. Accessed 4 March 2009.
44. Jia G, Belli M, Blasi M, Marchetti A, Rosamilia S, Sansone U. 210Pb and 210Po determination in environmental samples. Appl Radiat Isot 2000; 53:115-120.
45. Jia G, Belli M, Blasi M, Marchetti A, Rosamilia S, Sansone U. Determination of 210Pb and 210Po in mineral and biological environmental samples. J Radioan Nucl Chem 2001; 247:491-499.
46. Matthews KM, Kim CK, Martin P. Determination of 210Po in environmental materials: A review of analytical methodology. Appl Radiat Isot 2007; 65:267-279.
47. International Atomic Energy Agency (IAEA). Diagnosis and Treatment of Radiation Injuries Safety Reports Series No. 2; 1998.
48. Goans R. Update on the treatment of internal contamination. In: Ricks R, Berger M, O'Hara F, eds. The Medical Basis for Radiation-Accident Preparedness. New York: Parthenon; 2002:201-216.
49. Akashi M. Initial symptoms of three victims in the Tokaimura accident. In: Ricks R, Berger M, O'Hara F, eds. The Medical Basis for Radiation-Accident Preparedness. New York: Parthanon; 2002: 303-311.
50. Ishii T, Futami S, Nishida M, Suzuki T, Sakamoto T, Suzuki N, Maekawa K. Brief note and evaluation of acute-radiation syndrome and treatment of a Tokai-mura criticality accident patient. J Radiat Res 2001;42(Suppl.):S167-S182.
51. Maekawa K. Overview of the medical care for highly exposed victims in the Tokaimura accident. In: Ricks R, Berger M, O'Hara F, eds. The Medical Basis for Radiation-Accident Preparedness. New York: Parthenon; 2002:313-318.
52. Gerber G, Thomas RG. Guidebook for the treatment of accidental internal radionuclide contamination of workers. Radiat Prot Dosimetry 1992; 41:3-49.
53. Stannard JN, Haydon H. The effect of BAL (British Anti-Lewisite) on distribution and excretion of orally administered polonium. University of Rochester Atomic Energy Report 1956; UR-429.
54. Rencova J, Volf V, Jones MM, Singh PK. Relative effectiveness of dithiol and dithiocarbamate chelating agents in reducing retention of polonium-210 in rats. Int J Radiat Biol 1993; 63:223-232.
55. Rencova J, Volf V, Jones MM, Singh PK. Decorporation of polonium from rats by new chelating agents. Radiat Prot Dosimetry 1994; 53:311-313.
56. Volf V, Rencova J, Jones MM, Singh PK. Combined chelation treatment for polonium after simulated wound contamination in rat. Int J Radiat Biol 1995; 68:395-404.
57. Hursh JB. Effect of BAL on survival of rats after lethal doses of polonium. Proc Soc Exp Biol Med 1952; 79(2):210-212.
58. Aposhian HV, Dart RC, Aposhiam MM, Dawson BV. Tissue decorporation of polonium-210 in rats by DMPA. Res Commun Chem Pathol Pharmacol 1987; 58:157-171.
59. NCRP. Quick Reference Information. Recommendations of the National Council on Radiation Protection and Measurements. http:// www.afrri.usuhs.mil/ outreach/pdf/ncrp65section2-may2005-1.pdf. Accessed 17 April 2009.
60. Volf V. The effect of chelating agents on the distribution of 210Po in rats. Cell Mol Life Sci 1973; 29:307-308.
61. Bogdan GM, Aposhian HV. N-(2,3-Dimercaptopropyl)phthalamidic acid (DMPA) increases polonium-210 excretion. Biol Met 1990; 3:232-236.
62. Parfenov YD, Izergina AG, Mikhailovich SM. Effect of oxathiol on the uptake of absorbed doses from polonium 210 in the rat. Health Phys 1974; 26:199-202.
63. Parfenov YD, Konstantinova TP, Altuchova GA. Oxathiol effects on 210Po retention in the dogs' organs. Strahlentherapie 1974; 148:173-179.
64. Rencova J, Volf V, Jones MM, Singh PK, Filgas R. Bis-dithiocarbamates: Effective chelating agents for mobilization of polonium-210 from rat. Int J Radiat Biol 1995; 67:229-234.
65. Rencova J, Volf V, Jones MM, Singh PK. Mobilization and detoxification of polonium-210 in rats by 2,3-dimercaptosuccinic acid and its derivatives. Int J Radiat Biol 2000; 76:1409-1415.
66. Lincoln TA. Importance of initially management of persons internally contaminated with radionuclides. Am Indus Hygeine Assoc J 1976; 37:16-21.
67. REMM. Managing Internal Contamination. http://www.remm.nlm.gov/ isotopestable.pdf. Accessed 6 March 2009.
68. Waller EA, Stodilka RZ, Leach K, Prud'homme-Lalonde L. Literature Survey on Decorporation of Radionuclides from the Human Body. Ottawa: Defence R&D Canada; 2002.
69. Health Protection Agency. Polonium 210. http://www.hpa.org.uk/webw/ HPAweb&Page&HPAwebAutoListName/Page/1204619486699? p= 1204619486699. Accessed 8 August 2008.
70. Anderson J, Spitz H, Daniels R. Population monitoring for acute exposure to 210Po. J Occup Environ Med 2008; 50:916-923.
71. Valentin J. Preface: Doses to the embryo and fetus from intakes of radionuclides by the mother. Ann ICRP 2001; 31:7-515.
72. International Commission on Radiological Protection. Doses to the embryo and fetus from intakes of radionuclides by the mother; Ann ICRP 2001; 31: 1-518.
73. Harrison J, Phipps A, Stather J. Doses to infants from radionuclides ingested in mothers' milk. Ann ICRP 2004; 34(3-4): 1-282.
74. Stather JW, Phipps AW, Harrison JD, Eckerman KF, Smith TJ, Fell TP, Nosske D. Dose coefficients for the embryo and fetus following intakes of radionuclides by the mother. Radiat Prot Dosimetry 2003; 105:257-264.
75. Stather JW, Harrison JD, Kendall GM. Radiation doses to the embryo and fetus following intakes of radionuclides by the mother. Radiat Prot Dosimetry 1992; 41:111-118.
76. Haines JW, Harrison JD, Pottinger HE, Phipps AW. Transfer of polonium to the embryo and foetus of rat and guinea pig. Int J Radiat Biol 1995; 67:381-390.
77. Paquet F, Poncy JL, Ham GJ, Prosser SL, Harrison JD. Transfer of polonium, neptunium, plutonium and americium to the primate fetus. Radiat Prot Dosimetry 1998; 79:303-306.
78. Centers for Disease Control and Prevention. Prenatal Radiation Exposure: A Fact Sheet for Physicians. http://www.bt.cdc.gov/ radiation/prenatalphysician. asp. Accessed 5 March 2009.
79. Valentin J, ed. Annals of the ICRP, Publication 84: Pregnancy and Medical Radiation, International Commission on Radiological Protection. Vol.30, No.1. Tarrytown, New York: Pergamon, Elsevier Science, Inc.; 2000.